sotalol has been researched along with Marfan Syndrome, Type I in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol was partially effective for AVRT, however, it did not prevent AF, RF ablation cured all arrythmias." | 5.35 | [Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome]. ( Bodalski, R; Orczykowski, M; Szufladowicz, E; Szumowski, L; Walczak, F; Zakrzewska-Koperska, J, 2008) |
| "Sotalol was partially effective for AVRT, however, it did not prevent AF, RF ablation cured all arrythmias." | 1.35 | [Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome]. ( Bodalski, R; Orczykowski, M; Szufladowicz, E; Szumowski, L; Walczak, F; Zakrzewska-Koperska, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orczykowski, M | 1 |
| Szumowski, L | 1 |
| Szufladowicz, E | 1 |
| Bodalski, R | 1 |
| Zakrzewska-Koperska, J | 1 |
| Walczak, F | 1 |
1 other study available for sotalol and Marfan Syndrome, Type I
| Article | Year |
|---|---|
[Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome].
Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Humans; Male; Marfan Syndrome | 2008 |